|本期目录/Table of Contents|

[1]沈国栋,谭伟龙.新型冠状病毒肺炎流行期间军队医疗机构面临的采供血和输血风险与安全防护[J].医学研究与战创伤救治(原医学研究生学报),2020,22(4):342-345.[doi:10.3969/j.issn.1672-271X.2020.04.002]
　SHEN Guo-dong,TAN Wei-long.Risk and safety of blood collection and transfusion in military medical institutions during COVID-19 epidemic[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(4):342-345.[doi:10.3969/j.issn.1672-271X.2020.04.002]
点击复制

新型冠状病毒肺炎流行期间军队医疗机构面临的采供血和输血风险与安全防护()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第22卷
期数:
2020年4期
页码:
342-345
栏目:
出版日期:
2020-07-20

文章信息/Info

Title:
Risk and safety of blood collection and transfusion in military medical institutions during COVID-19 epidemic
作者:
沈国栋; 谭伟龙
作者单位：210002 南京，东部战区总医院秦淮医疗区输血医学科（沈国栋）；210002 南京，东部战区疾病预防控制中心（谭伟龙）
Author(s):
SHEN Guo-dong1;  TAN Wei-long2
(1.Department of Transfusion Medicine, Qinhuai Medical Treatment Area of General Hospital of Eastern Theater Command，PLA，Nanjing 210002，Jiangsu，China; 2. Center of Diseases Prevention and Control of Eastern Theater Command，PLA，Nanjing 210002, Jiangsu,China)
关键词:
新型冠状病毒肺炎; 输血风险; 安全防护
Keywords:
COVID-19;  risk of blood transfusion;  safety protection
分类号:
R184.1
DOI:
10.3969/j.issn.1672-271X.2020.04.002
文献标志码:
A
摘要:
新型冠状病毒肺炎（COVID-19）流行时期，军队医疗机构是所在地区军地伤病员诊疗救治的重要场所，防止医疗机构因采供血和输血导致院内交叉感染是一项重要而又紧迫的工作。非采供血军队医疗机构主要是由地方血液中心保障血液供应，疫情期间，血液和人员都有一定的潜在风险。文章通过分析COVID-19流行特征，围绕血液的采集、制备、运输、储存以及使用等过程中相关人员的潜在风险，提出有针对性的安全防护措施，使采血、输血和用血全过程安全可靠。
Abstract:
During the epidemic period of corona virus disease 2019 (COVID-19), military medical institutions are a key place for the treatment and treatment of wounded and sick military personnel in the region. It is an important and urgent task to prevent the cross-infection caused by blood collection, blood supply and transfusion in medical institutions. Non-blood collection and supply military medical institutions mainly rely on local blood centers to ensure a blood supply. During the epidemic, both blood and personnel have certain potential risks. This paper will analyze the epidemic characteristics of COVID-19 and the potential risks to relevant personnel in the process of blood collection, preparation, transportation, storage and use, and propose targeted safety protection measures to make the whole process of blood collection, transfusion and use safe and reliable.

参考文献/References:

[1]Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020,395(10223):497-506.
[2]Yang XB, Yu Y, Xu JQ, et al.Clinical Course and Outcomes of Critically Ill Patients With SARS-CoV-2 Pneumonia in Wuhan, China: A Single-Centered, Retrospective, Observational Study[J].Lancet Respir Med，2020，8(5):475-481.
[3]Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China[J]. N Engl J Med，2020，382(18):1708-1720.
[4]中华人民共和国国家卫生健康委员会. 新型冠状病毒肺炎诊治方案（试行第七版）[EB/OL]. (2020-03-03).http://www.nhc.gov.cn/yzygj/s7653p/202003/202046c209294a202007dfe202004cef202080dc202007f205912eb201989.shtml.
[5]Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention [J].JAMA, 2020. doi: 10.1001/jama.2020.2648.
[6]Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature, 2020.doi: 10.1038/s41586-41020-42012-41587.
[7]中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析[J]. 中华流行病学杂志, 2020,41(2):145-151.
[8]Ji YP, Ma ZR, Peppelenbosch MP, et al.Potential association between COVID-19 mortality and health-care resource availability[J].Lancet Glob Health, 2020,8(4):e480. doi: 10.1016/S2214-109X(20)30068-1.
[9]Chang D, Xu HW, Rebaza A, et al.Protecting health-care workers from subclinical coronavirus infection[J].Lancet Respir Med, 2020,8(3):e13. doi: 10.1016/S2213-2600(20)30066-7.
[10]Huang R, Xia J, Chen YX, et al.A Family Cluster of SARS-CoV-2 Infection Involving 11 Patients in Nanjing, China[J].Lancet Infect Dis, 2020,20(5):534-535. doi: 10.1016/S1473-3099(20)30147-X.
[11]钟慧钰, 赵珍珍, 宋兴勃, 等. 新型冠状病毒核酸临床检测要点及经验[J]. 国际检验医学杂志, 2020,41(5):523-526.
[12]施邵瑞，聂滨，郭渝，等. 新型冠状病毒肺炎病例多种生物样本的病毒核酸检测结果[J]. 华西医学, 2020,35(2):132-136.
[13]AABB. Aabb’s optional resources (toolkit) for fda’s communication to blood establishments regarding the COVID-19 outbreak[EB/OL]. 2020.http://www.aabb.org/advocacy/regulatorygovernment/Documents/Impact-of-2019-Novel-Coronavirus-on-Blood-Donation.pdf.
[14]Centers for disease control and prevention. How COVID-19 spreads [EB/OL]. 2020.https://www.cdc.gov/coronavirus/2019-ncov/about/transmission.html.
[15]Kampf G. Potential role of inanimate surfaces for the spread of coronaviruses and their inactivation with disinfectant agents[J]. Infect Prev Pract, 2020.https://doi.org/10.1016/j.infpip.2020.100044.
[16]中华人民共和国国家卫生健康委员会. 新型冠状病毒肺炎防控方案（第五版）[EB/OL]. 2020-02-21. http://www.nhc.gov.cn/jkj/s3577/202002/a5d6f7b8c48c451c87dba14889b30147.shtml.
[17]中华医学会检验分会. 2019新型冠状病毒肺炎临床实验室检测的生物安全防护指南（试行第一版）[EB/OL].2020-02-20. http://www.cslm.org.cn/cn/news.asp?id=73.html.
[18]谢军, 林宝丽, 张清华,等. 新型冠状病毒肺炎期间医院防控中分级消杀的探讨[J]. 东南国防医药, 2020,22(3):310-312.
[19]王桂玲, 陈春霞, 于晓玲,等. 新型冠状病毒肺炎防控中的综合性医院门诊管理措施与效果分析[J]. 医学研究生学报, 2020,33(5):521-524.

相似文献/References:

[1]杨艳,王佳佳,汪文妮,等.新型冠状病毒肺炎期间军队医院老年病房的防控管理[J].医学研究与战创伤救治(原医学研究生学报),2020,22(4):434.[doi:10.3969/j.issn.1672-271X.2020.04.024]
[2]郑翠霞,崔绘丽,吴栋云,等.新型冠状病毒肺炎恢复期血浆治疗对重型患者活动耐力的影响[J].医学研究与战创伤救治(原医学研究生学报),2020,22(5):487.[doi:10.3969/j.issn.1672-271X.2020.05.008]
　ZHENG Cui-xia,7,CUI Hui-li,et al.Novel coronavirus pneumonia recovery plasma treatment on heavy patient’s activity endurance influence[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(4):487.[doi:10.3969/j.issn.1672-271X.2020.05.008]
[3]王颖,钟勇,金涛,等.新型冠状病毒肺炎期间做好军队老干部防疫工作的实践与思考[J].医学研究与战创伤救治(原医学研究生学报),2020,22(5):552.[doi:10.3969/j.issn.1672-271X.2020.05.026]
[4]陈伟,施涛,王少华,等.新型冠状病毒肺炎疫情期间医院发热诊区的军队人员管理实践[J].医学研究与战创伤救治(原医学研究生学报),2020,22(5):555.[doi:10.3969/j.issn.1672-271X.2020.05.027]
[5]金娥,陈珺,陈丽珍,等.新型冠状病毒肺炎疫情期间血液净化室防控实践[J].医学研究与战创伤救治(原医学研究生学报),2020,22(5):558.[doi:10.3969/j.issn.1672-271X.2020.05.028]
[6]周莉萍,黄迎春,浦嘉丽,等.思维导图在新型冠状病毒肺炎疫情期间辅助护士优化预检筛查流程中的应用[J].医学研究与战创伤救治(原医学研究生学报),2020,22(6):658.[doi:10.3969/j.issn.1672-271X.2020.06.023]
[7]袁力,陈醒,孙伟,等.援鄂医疗队在抗击新型冠状病毒肺炎中的药品保障实践与思考[J].医学研究与战创伤救治(原医学研究生学报),2020,22(6):661.[doi:10.3969/j.issn.1672-271X.2020.06.024]
[8]刘颖,伏海燕,李美玲,等.新型冠状病毒肺炎疫情期间医院生殖中心防控管理探讨[J].医学研究与战创伤救治(原医学研究生学报),2020,22(6):664.[doi:10.3969/j.issn.1672-271X.2020.06.025]
[9]赵承奇,靳增华,王雪芬,等.新型冠状病毒肺炎治疗药物的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2021,23(01):58.[doi:10.3969/j.issn.1672-271X.2021.01.001]
　ZHAO Cheng-qi,JIN Zeng-hua,WANG Xue-fen,et al.Currentstatus andadvances for development of drugs to treat coronavirus disease 2019[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2021,23(4):58.[doi:10.3969/j.issn.1672-271X.2021.01.001]
[10]蔡玉龙,刘炯,夏国际,等.托珠单抗治疗高龄新型冠状病毒肺炎患者的临床疗效[J].医学研究与战创伤救治(原医学研究生学报),2021,23(01):75.[doi:10.3969/j.issn.1672-271X.2021.01.001]

备注/Memo

备注/Memo:
基金项目：新型冠状病毒感染性肺炎技术创新与应用开发研究项目（CSTC020JSCX-fyzx0009）
更新日期/Last Update: 2020-07-13